• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    iHuman Inc. Announces Second Quarter 2025 Unaudited Financial Results

    9/18/25 4:30:00 AM ET
    $IH
    Other Consumer Services
    Real Estate
    Get the next $IH alert in real time by email

    BEIJING, Sept. 18, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the second quarter ended June 30, 2025.

    (PRNewsfoto/iHuman Inc.)

    Second Quarter 2025 Highlights

    • Revenues were RMB200.2 million (US$27.9 million), compared with RMB215.1 million in the same period last year.
    • Gross profit was RMB135.7 million (US$19.0 million), compared with RMB151.7 million in the same period last year.
    • Operating income was RMB19.5 million (US$2.7 million), compared with RMB18.8 million in the same period last year.
    • Net income was RMB31.9 million (US$4.5 million), compared with RMB24.7 million in the same period last year.
    • Average total MAUs[1] for the second quarter were 23.72 million, compared with 24.57 million in the same period last year.

     

    [1] "Average total MAUs" refers to the monthly average of the sum of the MAUs of each of the Company's apps during a specific period, which is counted based on the number of unique mobile devices through which such app is accessed at least once in a given month, and duplicate access to different apps is not eliminated from the total MAUs calculation.

    Dr. Peng Dai, Director and Chief Executive Officer of iHuman, commented, "During the second quarter, we continued to advance our product roadmap and expand our international presence with several key updates. Our flagship app, iHuman Chinese—long recognized as an industry benchmark—introduced new features to make character exploration more intuitive and engaging. One specific highlight is the new photo recognition function that covers most daily-use Chinese characters. Children can simply take a picture of an unfamiliar character, and the app will instantly display its meaning, related words, example sentences, and cultural context, seamlessly turning everyday curiosity into a learning opportunity. We also launched a speaking feature that uses intelligent voice analysis to provide real-time feedback on pronunciation, helping children build confidence and fluency in verbal expression through practice.  

    Internationally, we launched a major upgrade to Aha Makeover, transforming it from a traditional styling experience into a vibrant, story-driven world. The update introduces missions, a tiered rewards system, and an expansive world map with different themed zones. The update also features a new virtual girl group of five original characters, each with a distinctive style and personality. Users can interact with them through various creative activities, such as experimenting with hairstyles, applying makeup, mixing and matching outfits, and personalizing rooms in a cozy virtual home. These interactions unlock rewards and advance the storyline, sparking users' creativity through diverse challenges. By combining character-led narratives with creative styling tools and engaging missions, the update delivers a distinctive and immersive experience that strengthens user engagement over time.

    We also took a major step forward in our global content strategy by establishing a strategic partnership with Cricket Media, a highly respected children's brand with more than five decades of experience and strong ties to schools, libraries, and households across the U.S. By leveraging Cricket Media's award-winning library—spanning genres like science, art, history, poetry, comics, and fiction—and our proven expertise in content digitization, edutainment, and interactive learning design, we are reimaging these classic resources for the digital age. Recently, we jointly launched Reading Stars, an intuitive app that retains the depth of traditional reading while offering interactive activities, motivating rewards, and personalized pathways to create a richer experience for young readers. This partnership not only introduces a compelling new reading product, but also deepens our presence in the U.S. education and consumer markets, bolsters our brand recognition abroad, and provides an effective platform for building long-term distribution channels and localized product offerings.

    Building on our strength in digital products, we are also expanding our entertainment content through our animation studio, Kunpeng. Our flagship Cosmicrew franchise, which first aired in 2018, remains a long-standing favorite among children and one of the most recognized and beloved names in its category. This summer, Cosmicrew continued its strong performance across major streaming platforms, underscoring its enduring popularity. Within the franchise, the Super Mecha Dinosaurs subseries has also built a devoted fanbase. In May, we released a new season that quickly attracted broad viewership on leading streaming platforms, further expanding the series' strong following. Importantly, as an integral part of iHuman's ecosystem, Kunpeng's original IPs not only broaden our entertainment lineup but also further increase the visibility of our overall IP portfolio within iHuman apps. This strengthens user engagement, creating a self-reinforcing flywheel where education and entertainment are closely integrated and amplify each other over time.

    By continuing to innovate, expanding our global footprint, and growing our entertainment portfolio, we are strengthening the foundation for long-term growth and creating more opportunities to engage audiences worldwide."

    Ms. Vivien Weiwei Wang, Director and Chief Financial Officer of iHuman, added, "We are pleased to deliver another solid quarter of results, marking our 14th consecutive quarter of profitability. This achievement is a testament to our disciplined execution and firm commitment to sustainable development. This quarter, we continued to strengthen our product portfolio and expand collaboration with ecosystem partners, creating new synergies and opportunities that lay a strong foundation for long-term growth. We are also actively expanding the role of AI across our operations, applying it not only to enrich user experiences but also to reimagine our operational processes. From automating routine tasks and streamlining workflows to enhancing data-driven insights, AI is enabling us to respond faster, operate more precisely, and capture greater efficiencies across the board.

    Backed by an industry-leading product lineup, a healthy balance sheet, and an agile operating model, we are well positioned to capitalize on new opportunities, scale globally, and continue creating value for our shareholders."

    Second Quarter 2025 Unaudited Financial Results

    Revenues

    Revenues were RMB200.2 million (US$27.9 million), compared with RMB215.1 million in the same period last year. The decrease in revenues was primarily due to the decline in China's newborn population and more conservative consumer spending.

    Average total MAUs for the quarter were 23.72 million, compared with 24.57 million in the same period last year.

    Cost of Revenues

    Cost of revenues was RMB64.4 million (US$9.0 million), compared with RMB63.4 million in the same period last year.

    Gross Profit and Gross Margin

    Gross profit was RMB135.7 million (US$19.0 million), compared with RMB151.7 million in the same period last year. Gross margin was 67.8%, compared with 70.5% in the same period last year. The decrease in gross margin was mainly due to the diversification and structural upgrades of the Company's product portfolio.

    Operating Expenses

    Total operating expenses were RMB116.3 million (US$16.2 million), a decrease of 12.5% from RMB132.9 million in the same period last year.

    Research and development expenses were RMB52.8 million (US$7.4 million), a decrease of 7.7% from RMB57.2 million in the same period last year, primarily due to savings in payroll-related and outsourcing expenses.  

    Sales and marketing expenses were RMB41.3 million (US$5.8 million), a decrease of 19.5% from RMB51.3 million in the same period last year, primarily due to cost savings in marketing activities. 

    General and administrative expenses were RMB22.1 million (US$3.1 million), a decrease of 9.3% from RMB24.4 million in the same period last year, primarily due to savings in payroll-related expenses as well as other administrative expenses. 

    Operating Income

    Operating income was RMB19.5 million (US$2.7 million), compared with RMB18.8 million in the same period last year.

    Net Income

    Net income was RMB31.9 million (US$4.5 million), compared with RMB24.7 million in the same period last year.

    Basic and diluted net income per ADS were RMB0.62 (US$0.09) and RMB0.60 (US$0.08), respectively, compared with RMB0.47 and RMB0.45 in the same period last year. Each ADS represents five Class A ordinary shares of the Company.

    Deferred Revenue and Customer Advances

    Deferred revenue and customer advances were RMB240.0 million (US$33.5 million) as of June 30, 2025, compared with RMB283.3 million as of December 31, 2024.

    Cash, Cash Equivalents and Short-term Investments

    Cash, cash equivalents and short-term investments were RMB1,100.1 million (US$153.6 million) as of June 30, 2025, compared with RMB1,168.7 million as of December 31, 2024. The decrease was primarily due to the payment of annual bonuses to employees and dividends in the first half of the year.

    Exchange Rate Information

    The U.S. dollar (US$) amounts disclosed in this press release, except for those transaction amounts that were actually settled in U.S. dollars, are presented solely for the convenience of the reader. The conversion of Renminbi (RMB) into US$ in this press release is based on the exchange rate set forth in the H.10 statistical release of the Board of Governors of the Federal Reserve System as of June 30, 2025, which was RMB7.1636 to US$1.00. The percentages stated in this press release are calculated based on the RMB amounts.

    Non-GAAP Financial Measures

    iHuman considers and uses non-GAAP financial measures, such as adjusted operating income, adjusted net income and adjusted diluted net income per ADS, as supplemental metrics in reviewing and assessing its operating performance and formulating its business plan. The presentation of non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). iHuman defines adjusted operating income, adjusted net income and adjusted diluted net income per ADS as operating income, net income and diluted net income per ADS excluding share-based compensation expenses, respectively. Adjusted operating income, adjusted net income and adjusted diluted net income per ADS enable iHuman's management to assess its operating results without considering the impact of share-based compensation expenses, which are non-cash charges. iHuman believes that these non-GAAP financial measures provide useful information to investors in understanding and evaluating the Company's current operating performance and prospects in the same manner as management does, if they so choose.

    Non-GAAP financial measures are not defined under U.S. GAAP and are not presented in accordance with U.S. GAAP. Non-GAAP financial measures have limitations as analytical tools, which possibly do not reflect all items of expense that affect our operations. Share-based compensation expenses have been and may continue to be incurred in our business and are not reflected in the presentation of the non-GAAP financial measures. In addition, the non-GAAP financial measures iHuman uses may differ from the non-GAAP measures used by other companies, including peer companies, and therefore their comparability may be limited. The presentation of these non-GAAP financial measures is not intended to be considered in isolation from or as a substitute for the financial information prepared and presented in accordance with GAAP.

    Safe Harbor Statement

    This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Statements that are not historical facts, including statements about iHuman's beliefs and expectations, are forward-looking statements. Among other things, the description of the management's quotations in this announcement contains forward-looking statements. iHuman may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the "SEC"), in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: iHuman's growth strategies; its future business development, financial condition and results of operations; its ability to continue to attract and retain users, convert non-paying users into paying users and increase the spending of paying users, the trends in, and size of, the market in which iHuman operates; its expectations regarding demand for, and market acceptance of, its products and services; its expectations regarding its relationships with business partners; general economic and business conditions; regulatory environment; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in iHuman's filings with the SEC. All information provided in this press release is as of the date of this press release, and iHuman does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

    About iHuman Inc.

    iHuman Inc. is a leading provider of tech-powered, intellectual development products in China that is committed to making the child-upbringing experience easier for parents and transforming intellectual development into a fun journey for children. Benefiting from a deep legacy that combines nearly three decades of experience in the parenthood industry, superior original content, advanced high-tech innovation DNA and research & development capabilities with cutting-edge technologies, iHuman empowers parents with tools to make the child-upbringing experience more efficient. iHuman's unique, fun and interactive product offerings stimulate children's natural curiosity and exploration. The Company's comprehensive suite of innovative and high-quality products include self-directed apps, interactive content and smart devices that cover a broad variety of areas to develop children's abilities in speaking, critical thinking, independent reading and creativity. Leveraging advanced technological capabilities, including 3D engines, AI/AR functionality, and big data analysis on children's behavior & psychology, iHuman believes it will continue to provide superior experience that is efficient and relieving for parents, and effective and fun for children, in China and all over the world, through its integrated suite of tech-powered, intellectual development products.

    For more information about iHuman, please visit https://ir.ihuman.com/. 

    For investor and media enquiries, please contact:

    iHuman Inc.

    Mr. Justin Zhang

    Investor Relations Director

    Phone: +86-10-5780-6606

    E-mail: [email protected]

    Christensen

    In China

    Ms. Alice Li

    Phone: +86-10-5900-1548

    E-mail: [email protected] 

    In the US

    Ms. Linda Bergkamp

    Phone: +1-480-614-3004

    E-mail: [email protected]

     

     

     

    iHuman Inc.



    UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS



    (Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")

    except for number of shares, ADSs, per share and per ADS data)





    December 31,



    June 30,



    June 30,



    2024



    2025



    2025



    RMB



    RMB



    US$













    ASSETS











    Current assets











    Cash and cash equivalents 

    1,123,292



    605,136



    84,474

    Short-term investments

    45,457



    495,000



    69,099

    Accounts receivable, net

    52,030



    56,318



    7,862

    Inventories, net

    23,475



    20,665



    2,885

    Amounts due from related parties

    2,051



    1,454



    203

    Prepayments and other current assets

    89,512



    85,224



    11,897

    Total current assets

    1,335,817



    1,263,797



    176,420

    Non-current assets











    Property and equipment, net

    3,476



    2,620



    366

    Intangible assets, net

    16,429



    14,918



    2,082

    Operating lease right-of-use assets

    14,885



    12,310



    1,718

    Long-term investment

    26,333



    26,333



    3,676

    Other non-current assets

    22,701



    15,110



    2,110

    Total non-current assets

    83,824



    71,291



    9,952

    Total assets

    1,419,641



    1,335,088



    186,372













    LIABILITIES











    Current liabilities











    Accounts payable

    30,233



    21,204



    2,960

    Deferred revenue and customer advances

    283,251



    240,012



    33,504

    Amounts due to related parties

    1,734



    1,950



    272

    Accrued expenses and other current liabilities

    126,501



    90,252



    12,599

    Dividend payable

    2,164



    -



    -

    Current operating lease liabilities

    3,661



    2,272



    317

    Total current liabilities

    447,544



    355,690



    49,652

    Non-current liabilities











    Non-current operating lease liabilities

    11,252



    10,006



    1,397

    Total non-current liabilities

    11,252



    10,006



    1,397

    Total liabilities

    458,796



    365,696



    51,049

    SHAREHOLDERS' EQUITY











    Ordinary shares (par value of US$0.0001 per share,

        700,000,000 Class A shares authorized as of

        December 31, 2024 and June 30, 2025; 125,122,382

        Class A shares issued and 116,084,207 outstanding as

        of December 31, 2024; 125,122,382 Class A shares

        issued and 112,724,757 outstanding as of June 30,

        2025; 200,000,000 Class B shares authorized,

        144,000,000 Class B ordinary shares issued and

        outstanding as of December 31, 2024 and June 30,

        2025; 100,000,000 shares (undesignated) authorized,

        nil shares (undesignated) issued and outstanding as of

        December 31, 2024 and June 30, 2025)

    185



    185



    26

    Additional paid-in capital

    996,657



    960,173



    134,035

    Treasury stock

    (26,296)



    (38,121)



    (5,321)

    Statutory reserves

    8,395



    8,395



    1,172

    Accumulated other comprehensive income

    24,009



    22,458



    3,135

    Retained earnings (accumulated deficit)

    (42,105)



    16,302



    2,276

    Total shareholders' equity

    960,845



    969,392



    135,323

    Total liabilities and shareholders' equity

    1,419,641



    1,335,088



    186,372

     

     

     

    iHuman Inc.



    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS



    (Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")

    except for number of shares, ADSs, per share and per ADS data)





    For the three months ended



    For the six months ended



    June 30,



    March 31,



    June 30,



    June 30,



    June 30,



    June 30,



    June 30,



    2024



    2025



    2025



    2025



    2024



    2025



    2025



    RMB



    RMB



    RMB



    US$



    RMB



    RMB



    US$





























    Revenues

    215,107



    210,439



    200,162



    27,942



    450,110



    410,601



    57,318

    Cost of revenues

    (63,372)



    (66,663)



    (64,414)



    (8,992)



    (130,264)



    (131,077)



    (18,297)





























    Gross profit

    151,735



    143,776



    135,748



    18,950



    319,846



    279,524



    39,021





























    Operating expenses



























    Research and development expenses

    (57,219)



    (55,385)



    (52,834)



    (7,375)



    (125,142)



    (108,219)



    (15,107)

    Sales and marketing expenses

    (51,263)



    (41,255)



    (41,279)



    (5,762)



    (106,258)



    (82,534)



    (11,521)

    General and administrative expenses

    (24,426)



    (25,539)



    (22,146)



    (3,091)



    (52,150)



    (47,685)



    (6,657)

    Total operating expenses

    (132,908)



    (122,179)



    (116,259)



    (16,228)



    (283,550)



    (238,438)



    (33,285)

    Operating income

    18,827



    21,597



    19,489



    2,722



    36,296



    41,086



    5,736

    Other income, net

    9,410



    8,000



    14,774



    2,062



    18,420



    22,774



    3,179

    Income before income taxes

    28,237



    29,597



    34,263



    4,784



    54,716



    63,860



    8,915

    Income tax expenses

    (3,574)



    (3,079)



    (2,374)



    (331)



    (7,751)



    (5,453)



    (761)

    Net income

    24,663



    26,518



    31,889



    4,453



    46,965



    58,407



    8,154





























    Net income per ADS:



























       - Basic

    0.47



    0.51



    0.62



    0.09



    0.89



    1.13



    0.16

       - Diluted

    0.45



    0.49



    0.60



    0.08



    0.86



    1.09



    0.15





























    Weighted average number of ADSs:



























       - Basic

    52,496,541



    51,888,345



    51,395,308



    51,395,308



    52,612,845



    51,640,464



    51,640,464

       - Diluted

    54,295,419



    53,884,134



    53,478,410



    53,478,410



    54,493,509



    53,679,910



    53,679,910





























    Total share-based compensation expenses included in:



























    Cost of revenues

    26



    8



    9



    1



    66



    17



    2

    Research and development expenses

    348



    110



    67



    9



    805



    177



    25

    Sales and marketing expenses

    45



    16



    16



    2



    91



    32



    4

    General and administrative expenses

    392



    104



    (5)



    (1)



    693



    99



    14





























     

     

     


    iHuman Inc.



    UNAUDITED RECONCILIATION OF GAAP AND NON-GAAP RESULTS



     (Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")

    except for number of shares, ADSs, per share and per ADS data)









    For the three months ended



    For the six months ended



    June 30,



    March 31,



    June 30,



    June 30,



    June 30,



    June 30,



    June 30,



    2024



    2025



    2025



    2025



    2024



    2025



    2025



    RMB



    RMB



    RMB



    US$



    RMB



    RMB



    US$





























    Operating income

    18,827



    21,597



    19,489



    2,722



    36,296



    41,086



    5,736

    Share-based compensation expenses

    811



    238



    87



    11



    1,655



    325



    45

    Adjusted operating income

    19,638



    21,835



    19,576



    2,733



    37,951



    41,411



    5,781





























    Net income

    24,663



    26,518



    31,889



    4,453



    46,965



    58,407



    8,154

    Share-based compensation expenses

    811



    238



    87



    11



    1,655



    325



    45

    Adjusted net income

    25,474



    26,756



    31,976



    4,464



    48,620



    58,732



    8,199





























    Diluted net income per ADS

    0.45



    0.49



    0.60



    0.08



    0.86



    1.09



    0.15

    Impact of non-GAAP adjustments

    0.02



    0.01



    0.00



    0.00



    0.03



    0.00



    0.00

    Adjusted diluted net income per ADS

    0.47



    0.50



    0.60



    0.08



    0.89



    1.09



    0.15





























    Weighted average number of ADSs – diluted

    54,295,419



    53,884,134



    53,478,410



    53,478,410



    54,493,509



    53,679,910



    53,679,910

    Weighted average number of ADSs – adjusted

    54,295,419



    53,884,134



    53,478,410



    53,478,410



    54,493,509



    53,679,910



    53,679,910

     

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ihuman-inc-announces-second-quarter-2025-unaudited-financial-results-302560225.html

    SOURCE iHuman Inc.

    Get the next $IH alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $IH

    DatePrice TargetRatingAnalyst
    12/30/2022$3.10Buy
    Citigroup
    More analyst ratings

    $IH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    iHuman Inc. Announces Second Quarter 2025 Unaudited Financial Results

    BEIJING, Sept. 18, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights Revenues were RMB200.2 million (US$27.9 million), compared with RMB215.1 million in the same period last year.Gross profit was RMB135.7 million (US$19.0 million), compared with RMB151.7 million in the same period last year.Operating income was RMB19.5 million (US$2.7 million), compared wi

    9/18/25 4:30:00 AM ET
    $IH
    Other Consumer Services
    Real Estate

    iHuman and Cricket Media Team Up to Launch Reading Stars

    Reading Stars seamlessly merges Cricket's award-winning content with iHuman's cutting-edge technology, creating an entirely new way for children to engage with reading. BEIJING and MCLEAN, Va., Sept. 18, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH), a leading provider of tech‑powered, intellectual development products in China, and Cricket Media, whose magazines have delighted families for more than 50 years, today announced the global launch of Reading Stars. Drawing on iHuman's expertise in content digitalization, edutainment and interactive learning design, along with Cricket Media's extensive library, the app transforms traditional reading resources into a dynamic digital experience that

    9/18/25 4:00:00 AM ET
    $IH
    Other Consumer Services
    Real Estate

    iHuman Inc. Announces First Quarter 2025 Unaudited Financial Results

    BEIJING, June 26, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Revenues were RMB210.4 million (US$29.0 million), compared with RMB235.0 million in the same period last year.Gross profit was RMB143.8 million (US$19.8 million), compared with RMB168.1 million in the same period last year.Operating income was RMB21.6 million (US$3.0 million), compared with

    6/26/25 6:12:00 AM ET
    $IH
    Other Consumer Services
    Real Estate

    $IH
    SEC Filings

    View All

    SEC Form 6-K filed by iHuman Inc.

    6-K - iHuman Inc. (0001814423) (Filer)

    9/18/25 7:08:02 AM ET
    $IH
    Other Consumer Services
    Real Estate

    SEC Form 6-K filed by iHuman Inc.

    6-K - iHuman Inc. (0001814423) (Filer)

    6/26/25 7:54:57 AM ET
    $IH
    Other Consumer Services
    Real Estate

    SEC Form 20-F filed by iHuman Inc.

    20-F - iHuman Inc. (0001814423) (Filer)

    4/28/25 4:01:23 PM ET
    $IH
    Other Consumer Services
    Real Estate

    $IH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup resumed coverage on iHuman with a new price target

    Citigroup resumed coverage of iHuman with a rating of Buy and set a new price target of $3.10

    12/30/22 8:45:58 AM ET
    $IH
    Other Consumer Services
    Real Estate

    $IH
    Financials

    Live finance-specific insights

    View All

    iHuman Inc. Announces Second Quarter 2025 Unaudited Financial Results

    BEIJING, Sept. 18, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights Revenues were RMB200.2 million (US$27.9 million), compared with RMB215.1 million in the same period last year.Gross profit was RMB135.7 million (US$19.0 million), compared with RMB151.7 million in the same period last year.Operating income was RMB19.5 million (US$2.7 million), compared wi

    9/18/25 4:30:00 AM ET
    $IH
    Other Consumer Services
    Real Estate

    iHuman Inc. Announces First Quarter 2025 Unaudited Financial Results

    BEIJING, June 26, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Revenues were RMB210.4 million (US$29.0 million), compared with RMB235.0 million in the same period last year.Gross profit was RMB143.8 million (US$19.8 million), compared with RMB168.1 million in the same period last year.Operating income was RMB21.6 million (US$3.0 million), compared with

    6/26/25 6:12:00 AM ET
    $IH
    Other Consumer Services
    Real Estate

    iHuman Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

    BEIJING, March 25, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024. Fourth Quarter 2024 Highlights Revenues were RMB232.7 million (US$31.9 million), compared with RMB250.4 million in the same period last year.Gross profit was RMB156.4 million (US$21.4 million), compared with RMB178.2 million in the same period last year.Operating income was RMB14.9 million (US$2.0 m

    3/25/25 4:03:00 AM ET
    $IH
    Other Consumer Services
    Real Estate

    $IH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by iHuman Inc. (Amendment)

    SC 13G/A - iHuman Inc. (0001814423) (Subject)

    3/8/22 10:06:04 AM ET
    $IH
    Other Consumer Services
    Real Estate

    SEC Form SC 13G/A filed by iHuman Inc. (Amendment)

    SC 13G/A - iHuman Inc. (0001814423) (Subject)

    2/14/22 4:13:25 PM ET
    $IH
    Other Consumer Services
    Real Estate

    SEC Form SC 13G filed

    SC 13G - iHuman Inc. (0001814423) (Subject)

    2/16/21 6:11:44 AM ET
    $IH
    Other Consumer Services
    Real Estate